Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report

J Glob Antimicrob Resist. 2021 Dec:27:157-159. doi: 10.1016/j.jgar.2021.09.005. Epub 2021 Sep 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • COVID-19*
  • Cefiderocol
  • Cephalosporins / therapeutic use*
  • Empyema, Pleural* / drug therapy
  • Empyema, Pleural* / microbiology
  • Humans
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa

Substances

  • Cephalosporins